08.20.24 -- Power Of Attorney For Cell Therapy Outsourcing

Our EMEA Advance Biotech Grant Program is open for European biotech startup companies to help them accelerate to clinic faster. Enter for a chance to win €148,400 in products & services. Learn more here.

Each month, Outsourced Pharma works in conjunction with PharmSource, part of GlobalData, to present its “Contract Manufacturing: Opportunities and Threats (CMOT) Report” to our readers. The report identifies CDMOs that might be impacted by key events affecting their clients, including company acquisitions, product acquisitions and licenses, product approvals, late clinical product terminations, and FDA rejections.

The dynamic nature of complex cell therapy-focused clinical trials requires individuals with a keen understanding of site and partner needs communicating effectively.

AAV has become an increasingly popular vector for gene therapy applications, yet ongoing challenges related to process and analytical development often require significant expertise to navigate.

Manufacturing mRNA products is a complex and challenging process that requires careful consideration at each stage. Learn more about the challenges and intricacies involved.

View the webinar and learn how efficient project management and optimized communication are cornerstones of a successful transfer process.

Manufacturing RNA-containing LNPs demands specialized expertise  Explore the challenges of RNA-LNP manufacturing and the advantages of outsourcing RNA-LNP formulations.

Examine the post-thaw segment QC results for 2,249 consecutive segments cut at our institution to create a benchmark of what is to be expected when interpreting segment testing.

The development and production of CGTs present unparalleled complexities. Learn how a partner with robust end-to-end services can help you overcome challenges at every step of the drug lifecycle.

Explore two projects that a focus on improving efficiency and productivity in manufacturing while reducing the cost of goods through process intensification.

Learn how a recent expansion into Western Pennsylvania is aiming to enable more biopharmaceutical firms to translate cutting-edge science and research into practical applications.

Our team of experienced engineers, scientists, researchers, analysts, and operators have expertise in a variety of modalities, equipment, technologies, platforms, and processes. 

We offer GMP services with detailed process characterization. Your project will benefit from the heavily documented quality-by-design program that surrounds the development of our platform GMP process and analytical methods.

Codex HiCap RNA Polymerase delivers enhanced safety, cost-effectiveness, and performance, empowering researchers to unlock the full potential of mRNA therapeutics.